37results about How to "Lower liver index" patented technology

The invention discloses a traditional Chinese medicine composition for treating fatty liver and relates to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared by raw materials in parts by weight: 10 parts of rhizoma alismatis, 6 parts of capillary artemisia, 10 parts of panax pseudoginseng, 10 parts of ligusticum wallichii, 20 parts of fructus aurantii immaturus, 20 parts of hawthorn, 10 parts of bupleurum, 15 parts of scutellaria baicalensis, 30 parts of rhizoma atractylodis, 5 parts of root of herbaceous peony, 6 parts of salvia miltiorrhiza and 10 parts of liquorice. The traditional Chinese medicine composition has very good treatment effect in the treatment of fatty liver and significant clinical generalization value.

The invention discloses a traditional Chinese medicine composition for treating an alcoholic liver, and relates to the technical field of the traditional Chinese medicine. Aiming at the defects that overall effective treatment is in shortage on an alcoholic liver disease at present while recurrence is easily generated in chemical treatment, and the curative effect cannot last in the prior art, the invention provides the traditional Chinese medicine composition for treating the alcoholic liver. The traditional Chinese medicine composition is prepared from the following materials in parts by weight: 10 parts of rhizoma alismatis, 15 parts of peach kernel, 6 parts of capillary artemisia,10 parts of pseudo-ginseng, 10 parts of ligusticum wallichii, 6 parts of root of red-rooted salvia, 20 parts of fructus aurantii, 20 parts of hawthorn, 10 parts of radix bupleuri, 12 parts of radix curcumae, 15 parts of scutellaria baicalensis, 30 parts of tribulusterrestris, 6 parts of polygonum cuspidatum and 10 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention has a good treatment effect in the aspect of treatment of the alcoholic liver disease, and has significant clinical popularization value.

The invention provides a taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder. The taraxacum oral liquid comprises the following active pharmaceutical ingredients in parts by weight: 10-50 parts of taraxacum, 10-20 parts of herba artemisiae scopariae, 10-20 parts of rabdosia serra, 10-20 parts of selfheal, 10-20 parts of radix bupleuri, 10-20 parts of radix paeoniae alba, 10-20 parts of corn silk, 10-20 parts of lalang grass rhizome, 10-20 parts of giant knotweed, 10-20 parts of euphrasia pectinata, 10-20 parts of scutellaria barbata, 10-20 parts of sedum sarmentosum, 10-20 parts of leonurus, 10-20 parts of trichosanthes kirilowi, 10-20 parts of cape jasmine fruit, 10-20 parts of herba ecliptae, 10-20 parts of polygonatum sibiricum, 10-20 parts of portulaca oleracea, 10-20 parts of radix rehmanniae, 10-20 parts of indigowoad root and 10-20 parts of lysimachia christinae Hance. The taraxacum oral liquid and the preparation method have the advantages that the traditional Chinese medicine extraction technology is greatly improved, so that toxic components in such Chinese herbs can be reduced to minimum, the taraxacum oral liquid can be absorbed by the human body, and the utilization ratio can be greatly improved.

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine composition and an application of the traditional Chinese medicine composition as a medicine for treating fatty liver. The traditional Chinese medicine composition for treating or preventing fatty liver comprises the following components in parts by weight: 5-15 parts of radix curcumae, 3-9 parts of poria cocos, 5-15 parts of pericarpium citri reticulatae, 5-15 parts of ligusticum wallichii, 18-23 parts of pinellia ternate, 18-23 parts of hawthorn, 5-15 parts of radix bupleuri, 15 parts of turmeric, 20-50 parts of semen cassiae, 2-7 parts of radix paeoniae alba, 3-9 parts of salviae miltiorrhizae and 5-15 parts of polygonum cuspidatum. The traditional Chinese medicine composition has a good curative effect on treatment of fatty liver and has a remarkable clinical application value.

The invention provides an NK cell combined with a mesenchymal stem cell, and application of a composition and an injection thereof in preparation of drugs for treating hepatitis and liver fibrosis. The NK cell combined with the mesenchymal stem cell and the composition and the injection thereof can be used for treating hepatitis B, can reduce liver indexes, activity of ALT and AST in serum and MDAcontent in liver tissue, and has the function of enhancing SOD activity. Therefore, the NK cell combined with the mesenchymal stem cell and the composition and the injection thereof provided by the invention can also be used for treating liver fibrosis.

The invention belongs to the technical field of medicine, and relates to a Chinese medicinal composition, in particular to a Chinese medicinal composition for treating chronic alcoholic toxic liver disease and a preparation method thereof. Aiming at the current technological defects that the chronic alcoholic toxic liver disease cannot be treated comprehensively and effectively and chemical treatment has the defects of high relapse rate and discontinuous curative effect, the Chinese medicinal composition for treating or preventing the chronic alcoholic liver toxic disease comprises the following components in parts by weight: 10 parts of corydalis tuber, 15 parts of fourstamen stephania root, 6 parts of virgate wormwood herb, 10 parts of glossy privet fruit, 10 parts of Szechuan lovage rhizome, 6 parts of Chinese angelica, 20 parts of sophora flower, 20 parts of tribulus terrestris, 10 parts of Chinese thorowax root, 12 parts of baikal skullcap root, 15 parts of baikal skullcap root, 30 parts of cassia twig, 6 parts of Indian buead and 10 parts of liquoric root. The Chinese medicinal composition has a very good treatment effect on the chronic alcoholic toxic liver disease, and has a remarkable clinical popularization value.

The present invention relates to a medicine for treating fat live of obesity. It is prepared with seven kinds of Chinese medicinal materials including giant knotwood, pinellia tuber, oriental water plantain, zedoary, peach kernel, prince's-feather fruit and licorice. The preparation process is also disclosed. The medicine has the functions of promoting diuresis, eliminating phlegm, promoting blood circulation and elimianting abdominal mass. It is used to treat fat liver of obesity caused by wetness phlegm stasis mainly. Clinical application shows that it has fast and obviously treating effect and no bad reaction.

The invention provides herba eupatorii oral liquid for clearing heat and removing dampness, and protecting liver and gallbladder. The oral liquid consists of the following medicinal raw materials in parts by weight: 10-50 parts of herba eupatorii, 10-20 parts of herba artemisiae scopariae, 10-20 parts of poria cocos, 10-20 parts of lysimachia christinae hance, 10-20 parts of dried orange peel, 10-20 parts of radix paeoniae rubra, 10-20 parts of rhizoma dryopteridis, 10-20 parts of corn stigma, 10-20 parts of lalang grass rhizome, 10-20 parts of herba taxilli, 10-20 parts of scutellaria baicalensis, 10-20 parts of abrus cantoniensis hance, 10-20 parts of szechwan Chinaberry fruit, 10-20 parts of euphrasia officinalis, 10-20 parts of coix seed, 10-20 parts of sedum sarmentosum, 10-20 parts of sculellaria barbata, 10-20 parts of plantain herb, 10-20 parts of herba portulacae, 10-20 parts of radix isatidis, 10-20 parts of glossy privet fruit, 10-20 parts of seed of Chinese dodder and 10-20 parts of rhizoma alismatis. The oral liquid disclosed by the invention has an effect on selectively lowering SGOT (serum glutamic-oxaloacetic transaminase), and the oral liquid, with a large dosage, is capable of lowering liver index, showing that the medicine is relatively good in effect on protecting liver and gallbladder, eliminating dampness, losing weight and expelling toxins.

The invention discloses a Chinese herba preparation for regulating lipid and reducing weight, made by sticktight, hawthorn, roxburghrose, medlar and salvia miltiorrhiza. The medicines are combined to achieve synergistic effect of efficacies of all medicines, thus effectively removing stasis and activating blood, helping digestion, nourishing liver and kidney and replenishing qi to invigorate the spleen. Most medicines in the invention are food and have definite curative effect, thus being applicable to application for a long time, and price is low, thus being easy to develop and apply.

The invention belongs to the field of traditional Chinese medicine, and relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating fatty liver and application for preparing medicine for preventing or treating fatty liver. Aiming at the defect that current fatty liver chemical treatment medicine is large in hepatotoxicity, the traditional Chinese medicine composition for treating or preventing fatty liver comprises 10 parts of fructus forsythia, 6 parts of chrysanthemum, 10 parts of bletilla striata, 10 parts of poria cocos, 20 parts of polygonum multiflorum, 20 pats of astragalus membranaceus, 10 parts of radix codonopsis, 15 parts of dried radix rehmanniae, 30 parts of atractylodes macrocephala koidz, 5 parts of red peony root, 6 parts of radix salviae milliorrhizae extracts and 10 parts of radix cynanchi panicullati. The traditional Chinese medicine composition has good treatment effect for treating fatty liver, and has remarkable clinical popularization value.

The invention provides a christina loosestrife herb oral liquid for clearing away heat, removing dampness, benefiting the bile and expelling toxin. The christina loosestrife herb oral liquid is prepared from the following raw materials in parts by weight: 10-50 parts of christina loosestrife herb, 10-20 parts of herba artemisiae scopariae, 10-20 parts of poria cocos, 10-20 parts of selfheal, 10-20 parts of gardenia, 10-20 parts of dandelion, 10-20 parts of lophatherum gracile, 10-20 parts of corn stigma, 10-20 parts of loranthus parasiticus, 10-20 parts of eupatorium, 10-20 parts of fructus forsythia, 10-20 parts of radix isatidis, 10-20 parts of pericarpium citri reticulatae, 10-20 parts of cortex moutan, 10-20 parts of oldenlandia diffusa, 10-20 parts of abrus cantoniensis hance, 10-20 parts of philippine flemingia roots, 10-20 parts of eyebright, 10-20 parts of purslane, 10-20 parts of endothelium corneum gigeriae galli, 10-20 parts of lentil and 10-20 parts of rhizoma atractylodis. The christina loosestrife herb oral liquid has relatively good effects of protecting the liver, benefiting the bile, removing dampness, losing weight and expelling toxin.

The invention belongs to the field of traditional Chinese medicines, and relates to preparation and lipid-lowering activity of homogeneous polysaccharides in a kudzu vine water extract. In-vivo experiments prove that the kudzu vine homogeneous polysaccharide QL separated from a Jiangxi genuine medicinal material namely kudzu vine has remarkable lipid-lowering activity, remarkably reduces the content of serum triglyceride and liver indexes, and can be used for developing potential safe and effective lipid-lowering medicines.

The invention provides dandelion oral liquid capable of protecting the liver and benefiting the gallbladder. The oral liquid is characterized by being prepared from, by weight, 10-50 parts of dandelion, 10-20 parts of herba artemisiae capillariae, 10-20 parts of serrate rabdosia herbs, 10-20 parts of selfheals, 10-20 parts of radix bupleuri, 10-20 parts of radix paeoniae alba, 10-20 parts of angelica sinensis, 10-20 parts of corn stigma, 10-20 parts of rhizoma imperatae, 10-20 parts of rhizoma polygoni cuspidati, 10-20 parts of radix aucklandiae, 10-20 parts of fructus schizandrae, 10-20 parts of semen boitae, 10-20 parts of lonicera japonica, 10-20 parts of radix trichosanthis, 10-20 parts of curcuma zedoary, 10-20 parts of herba ecliptae, 10-20 parts of radix polygoni multiflori preparata, 10-20 parts of semen plantaginis, 10-20 parts of fructus gardeniae, 10-20 parts of rehmannia roots and 10-20 parts of herba andrographitis. According to the dandelion oral liquid capable of protecting the liver and benefiting the gallbladder and a preparation method thereof, due to the fact that the extraction technique of the traditional Chinese medicine is greatly improved, the toxic ingredients in the traditional Chinese medicine is reduced to the minimum to be capable of being absorbed by a human body, and the utilization rate of the traditional Chinese medicine is greatly improved.

The invention discloses a traditional Chinese medicine composition for treating a chronic alcoholic liver disease and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the raw materials of white paeony root, rhizoma corydalis, hawthorn, rourstamen stephania root, tangerine peel, capillary artemisia, ligusticum wallichii, curcuma zedoaria, angelica sinensis, honeysuckle stem, flos sophorae, lotus aeedpod, tribulus terrestris, ligustrum lucidum, bupleurum, poria cocos, scutellaria baicalensis, cassia twig, jujube and glycyrrhiza. The traditional Chinese medicine composition has a very good therapeutic effect in the aspect of treating the chronic alcoholic liver disease and has remarkable clinic popularization value.

The invention discloses a preparation method and an application of pu-erh tea extractive with a blood fat reducing function. The preparation method comprises the following steps in sequence of: adding water to the pu-erh tea to leach; filtering the extracting liquid; absorbing by macroporous resin; eluting by ethanol-water solution; concentrating the leaching liquid until reaching a certain proportion; and drying the concentrate, thus obtaining the pu-erh tea extractive. According to the preparation method, the characteristic of high effective component content of the pu-erh tea extractive is utilized to prepare the tea drinks, tea bags, pu-erh cream and tea beverage which have the effects of obviously controlling the raise of the weight, reducing the liver index, fat index and LEE'S index, raising high-density lipoprotein cholesterol and reducing triglyceride.

The invention provides rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification. The rhubarb oral liquid is prepared from, by weight, 10-50 parts of rhubarb, 10-20 parts of oriental wormwood, 10-20 parts of poria cocos, 10-20 parts of self heal, 10-20 parts of cape jasmine, 10-20 parts of white peony roots, 10-20 parts of lophatherum gracile, 10-20 parts of corn stigma, 10-20 parts of cortex dictamni, 10-20 parts of polygonum cuspidatum, 10-20 parts of fructus forsythiae, 10-20 parts of radix isatidis, 10-20 parts of pericarpium citri reticulatae, 10-20 parts of Chinese waxgourd peel, 10-20 parts of radix trichosanthis, 10-20 parts of abrus cantoniensis hance, 10-20 parts of eclipta, 10-20 parts of eyebright, 10-20 parts of semen plantaginis, 10-20 parts of endothelium corneum gigeriae galli, 10-20 parts of hyacinth beans and 10-20 parts of suberect spatholobus stems. The rhubarb oral liquid has the effect of selectively lowering SGOT, and can decrease liver indexes when a large dose of rhubarb oral liquid is taken, and it shows that the rhubarb oral liquid has good effects of protecting livers, being beneficial to choleresis, removing dampness, losing weight and conducting detoxification.

The invention provides a medicine for preventing stoke. The medicine is prepared from the following raw materials in parts by weight: 10-20 parts of earthworm, 5-10 parts of Chinese angelica, 15-25 parts of root of kudzu vine, 4-10 parts of root of common peony, 3-8 parts of muscardine cadaver, 5-15 parts of ginseng, 10-15 parts of red flower, 8-15 parts of caulis spatholobi, 10-15 parts of centipede, 10-20 parts of pseudo-ginseng and 4-8 parts of radix polygonati officinalis. The medicine has the effect of preventing stroke and can be used for lowering morbidity of the stroke.

The invention provides rheum officinale oral liquid capable of protecting the liver and benefiting the gallbladder. The oral liquid is prepared from, by weight, 10-50 parts of rheum officinale, 10-20 parts of herba artemisiae capillariae, 10-20 parts of poria cocos, 10-20 parts of herba houttuyniae, 10-20 parts of radix bupleuri, 10-20 parts of radix paeoniae alba, 10-20 parts of angelica sinensis, 10-20 parts of corn stigma, 10-20 parts of herba cirsii, 10-20 parts of rhizoma polygoni cuspidati, 10-20 parts of wolfberries, 10-20 parts of glossy privet fruits, 10-20 parts of semen boitae, 10-20 parts of Chinese wax gourd peel, 10-20 parts of radix trichosanthis, 10-20 parts of curcuma zedoary, 10-20 parts of herba ecliptae, 10-20 parts of radix polygoni multiflori preparata, 10-20 parts of semen plantaginis, 10-20 parts of endothelium corneum gigeriae galli, 10-20 parts of rehmannia roots and 10-20 parts of isatis roots. According to the rheum officinale oral liquid capable of protecting the liver and benefiting the gallbladder and a preparation method thereof, due to the fact that the extraction technique of the traditional Chinese medicine is greatly improved, the toxic ingredients in the traditional Chinese medicine is reduced to the minimum to be capable of being absorbed by a human body, and the utilization rate of the traditional Chinese medicine is greatly improved.

The invention belongs to the technical field of medicine, and relates to a Chinese medicinal composition, in particular to a Chinese medicinal composition for treating chronic alcoholic toxic liver disease and a preparation method thereof. Aiming at the current technological defects that the chronic alcoholic toxic liver disease cannot be treated comprehensively and effectively and chemical treatment has the defects of high relapse rate and discontinuous curative effect, the Chinese medicinal composition for treating or preventing the chronic alcoholic liver toxic disease comprises the following components in parts by weight: 10 parts of corydalis tuber, 15 parts of fourstamen stephania root, 6 parts of virgate wormwood herb, 10 parts of glossy privet fruit, 10 parts of Szechuan lovage rhizome, 6 parts of Chinese angelica, 20 parts of sophora flower, 20 parts of tribulus terrestris, 10 parts of Chinese thorowax root, 12 parts of baikal skullcap root, 15 parts of baikal skullcap root, 30 parts of cassia twig, 6 parts of Indian buead and 10 parts of liquoric root. The Chinese medicinal composition has a very good treatment effect on the chronic alcoholic toxic liver disease, and has a remarkable clinical popularization value.

The invention belongs to the field of medicines and particularly relates to a pharmaceutical composition used for treating fatty liver and containing glucosamine. The pharmaceutical composition used for treating fatty liver and containing glucosamine comprises glucosamine and polyene phosphatidyl choline, and further comprises betahistine or pharmaceutical salt of betahistine. Experiments discover that the pharmaceutical composition provided by the invention can remarkably reduce a liver index of a rat suffering from the fatty liver as well as an ALT value and an AST value in blood plasma, has a remarkable fat-reducing effect, and has a remarkable treatment effect for the fatty liver. Moreover, the pharmaceutical composition can remarkably enhance the free radical scavenging capability of the body of the rat suffering from the fatty liver, reduce the lipid peroxidation degree of the body and improve the detoxification capability of the body, thereby better facilitating the rehabilitation of the fatty liver.

The invention belongs to the technical field of medicine, relates to a traditional Chinese medicine composition, and in particular relates to a traditional Chinese medicine composition for treating chronic alcoholic toxic liver disease and a preparation method thereof. Aiming at the current technical defects of lack of comprehensive and effective treatment on the chronic alcoholic toxic liver disease, easiness in relapse of chemical treatment, and inconstant curative effect, the invention provides the traditional Chinese medicine composition for treating chronic alcoholic toxic liver disease. The traditional Chinese medicine composition comprises the following components: 10 parts of rhizoma alismatis, 15 parts of Fourstamen Stephania root, 6 parts of herba artemisiae, 10 parts of fleece-flower root, 10 parts of rhizoma ligustici wallichii, 6 parts of angelica, 20 parts of hovenia dulcis, 20 parts of Chinese gall, 10 parts of radix bupleuri, 12 parts of rhizoma polygonati, 15 parts of Scutellaria baicalensis, 30 parts of Lycium barbarum L., 6 parts of Poria cocos, and 10 parts of liquorice. The traditional Chinese medicine composition has a very good treatment effect in the treatment of chronic alcoholic toxic liver disease, and has significant clinical promotion value.

The invention provides a cassia seed oral liquid with the functions of removing dampness and clearing heat and expelling toxins and benefiting the gallbladder. The cassia seed oral liquid comprises the following active pharmaceutical ingredients in parts by weight: 10-50 parts of cassia seed, 10-20 parts of baikal skullcap root, 10-20 parts of rehmannia root, 10-20 parts of virgate wormwood herb, 10-20 parts of corn stigma, 10-20 parts of figwort root, 10-20 parts of bitter orange, 10-20 parts of abrus herb, 10-20 parts of common selfheal fruit-spike, 10-20 parts of gynostemma pentaphyllum, 10-20 parts of mulberry fruit, 10-20 parts of cape jasmine fruit, 10-20 parts of turmeric root-tuber, 10-20 parts of linearstripe rabdosia herb, 10-20 parts of dried tangerine peel, 10-20 parts of herb of Regel eyebright, 10-20 parts of officinal magnolia bark, 10-20 parts of rhizoma atractylodis and 10-20 parts of indigowoad root. The body conditioning main points are as follows: the bowels are relaxed, diuresis is promoted and dampness is dissipated to clear heat, and dampness and heat are removed from urine and stool according to the principle that dampness is eliminated through purgation; and the bowels are relaxed and diuresis is promoted while the liver is soothed and dampness is eliminated by diuresis to clear heat through purgation.

The invention discloses application of short-chain fatty acid in prevention or / and treatment of liver injury. The short-chain fatty acid is a product of intestinal flora glycolysis dietary fibers, belongs to an endogenous substance, is small in toxic and side effects, simple in structure, easy to metabolize, convenient to obtain and low in price, and can improve liver functions, inhibit liver fatty degeneration, maintain intestinal health and prevent or / and treat liver injury.

The invention discloses a traditional Chinese medicine composition for treating fatty liver and relates to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared by raw materials in parts by weight: 10 parts of rhizoma alismatis, 6 parts of capillary artemisia, 10 parts of panax pseudoginseng, 10 parts of ligusticum wallichii, 20 parts of fructus aurantii immaturus, 20 parts of hawthorn, 10 parts of bupleurum, 15 parts of scutellaria baicalensis, 30 parts of rhizoma atractylodis, 5 parts of root of herbaceous peony, 6 parts of salvia miltiorrhiza and 10 parts of liquorice. The traditional Chinese medicine composition has very good treatment effect in the treatment of fatty liver and significant clinical generalization value.

The invention belongs to the field of biological medicine, and relates to a histidine dipeptide composition for repairing liver injury, the histidine dipeptide composition comprises the following effective components: carnosine, goose carnosine, corbicula fluminea extract, radix puerariae extract and radix astragali extract, and the mass ratio of the carnosine to the goose carnosine to the corbicula fluminea extract to the radix puerariae extract to the radix astragali extract in the composition is (50-60): (20-25): (5-10): (5-10): (5-10). The histidine dipeptide composition provided by the invention can effectively prevent and / or treat liver injury in a certain proportioning range, especially has excellent effects in repairing liver cell injury, preventing and / or treating liver injury caused by hypeluricemia and treating clinical liver cell injury type liver diseases, and has the advantages of cheap raw materials, simple preparation method, low cost, and no toxic effect.

The invention belongs to the field of traditional Chinese medicine, and relates to the preparation of homogeneous polysaccharide in water extract of pueraria root and its lipid-lowering activity. The present invention separates the homogeneous polysaccharide QL from Jiangxi Daodi medicinal material—— Pueraria lobata. The in vivo experiment proves that the homogeneous polysaccharide of Pueraria lobata has significant lipid-lowering activity, significantly reduces the content of serum triglyceride and liver index, and can be used to develop potential safe and effective drugs. Lipid-lowering drugs.

The invention relates to an application of atractylenolide III in preparation of a medicine for treating a non-alcoholic fatty liver disease. It is found that atractylenolide III can reduce liver lipid deposition, reduce liver indexes, significantly reduce serum blood fat levels and liver tissue TG and TC levels and activate related signal molecules of an AMPK / SIRT1 signal channel; the MDA level can be reduced, the SOD and GSH-Px levels are increased, and the oxidative stress is improved. The atractylenolide III can inhibit lipid deposition by activating an AMPK / SIRT1 signal channel, reduce the oxidative stress reaction of liver cells, improve the expression level of CPT1A and improve the oxidative stress of mitochondria at the same time, and play a role in treating the non-alcoholic fatty liver disease through the mechanism. The atractylenolide III is a plant-derived chemical substance, the preparation steps are simple, the environmental pollution is small, and the method is suitable for industrial production. Therefore, atractylenolide III can be used for preparing the medicine or health food for treating the non-alcoholic fatty liver disease.

The invention discloses an application of methylidyne artemisinin in preparation of a medicine for treating liver diseases. The methylidyne artemisinin is combined with a medicinal carrier to form a medicine preparation, such as dripping pills, tablets, powders, capsules, granules, injections, microcapsules, syrups or oral solutions. The methylidyne artemisinin can reduce serum ALT, serum AST and liver index of liver disease patients, can improve functions of liver, effectively relieves liver damage due to alcoholic liver and hepatitis, can significantly reduce contents of HA, PC III and IV-C in patients and has significant anti-liver cirrhosis effect. The invention develops clinical application range of the methylidyne artemisinin and finds novel medicine sources for treatment on liver diseases, such as the alcoholic liver damage, acute liver damage, liver cirrhosis and the like, and also has advantage on complete utilization of the methylidyne artemisinin.

The invention discloses a traditional Chinese medicine composition for treating non-alcoholic fatty liver and a preparation method thereof. The composition is prepared from the following medicinal plants or decoction pieces through extracting: 100-600 parts of scutellaria baicalensis and 100-600 parts of coptis chinensis. The composition disclosed by the invention has effects of inducing dieresis and dispersing blood stasis, clearing away heat and toxic materials, protecting the liver and descending the turbid, is widely used for fatty liver, chronic hepatitis and hepatic fibrosis caused by various causes, and has a better curative effect for various fatty livers caused by obesity, diabetes, hypertension, hepatitis, and the like.

The invention discloses a Chinese herba preparation for regulating lipid and reducing weight, made by sticktight, hawthorn, roxburghrose, medlar and salvia miltiorrhiza. The medicines are combined to achieve synergistic effect of efficacies of all medicines, thus effectively removing stasis and activating blood, helping digestion, nourishing liver and kidney and replenishing qi to invigorate the spleen. Most medicines in the invention are food and have definite curative effect, thus being applicable to application for a long time, and price is low, thus being easy to develop and apply.